Skip to main content
Cancer Explained
Donate
Beginner 3 min readSource checked

REACH: The EU's Chemical Safety Framework

What the REACH Regulation is, how it registers and controls chemicals, and how it can restrict or phase out carcinogens — based on ECHA.

Source

European Chemicals Agency

A woman in headscarf walks alone outdoors through a green wooded area
A woman in headscarf walks alone outdoors through a green wooded area

Key fact

REACH stands for Registration, Evaluation, Authorisation and Restriction of Chemicals.

The short answer

REACH is the EU's overarching chemical law. It requires companies to register chemicals and their hazards, lets the EU restrict or require authorisation for the most concerning substances, and can phase out carcinogens. Its motto: 'no data, no market.'

  • REACH stands for Registration, Evaluation, Authorisation and Restriction of Chemicals.

  • Companies must register chemicals and provide hazard and safety data.

  • The principle is 'no data, no market' — unregistered chemicals can't be sold.

  • The most concerning substances face authorisation or restriction.

Choose how you want to understand this

The full explanation.

The EU's big chemical law

If CLP is how the EU labels chemical hazards, REACH is how it manages chemicals across their whole life in the market. REACH stands for Registration, Evaluation, Authorisation and Restriction of Chemicals. It is one of the most far-reaching chemical laws in the world.

'No data, no market'

REACH flips a familiar burden. Regulators do not have to prove a chemical is dangerous before they act. Instead, industry has to show that chemicals can be used safely. The guiding principle is often summed up as "no data, no market." A company generally cannot make or sell a chemical in the EU unless it has registered it, with data on its hazards and safe use.

This front-loads safety information into the system. Hazards — including the power to cause cancer — are on record before products reach people.

The four steps in the name

REACH's name maps to its four jobs.

  • Registration. Companies register chemicals they make or import above set volumes, with hazard and safe-use data.
  • Evaluation. ECHA and member states review registrations. They can ask for more information or testing.
  • Authorisation. The most concerning substances go on a list that requires special permission to use. That pushes companies toward safer options.
  • Restriction. The EU can set limits or outright bans on making, selling, or using a substance.

How REACH handles carcinogens

Carcinogens get special attention. A carcinogen is often already classified under CLP. It can then be named a Substance of Very High Concern (SVHC) and put on the candidate list. From there it can move to:

  • The Authorisation List (Annex XIV). Companies then need EU permission, and there is a deadline — a "sunset date" — after which use is banned unless authorised.
  • A restriction under Annex XVII, which caps or bans specific uses across the EU.

This gives the EU a real way to phase out the most concerning carcinogens over time. It also pushes industry toward safer substitutes. (See Substances of Very High Concern for the detail.)

Why this reflects the EU's philosophy

REACH shows the EU's precautionary, hazard-aware approach. It asks for data up front and allows phase-outs based on the hazard itself. So it can act on carcinogens without waiting for a full real-world risk tally for every use. That is a sharp contrast with the more risk-based US system.

The bottom line

REACH is the EU's overarching chemical framework. It registers chemicals and their hazards, evaluates them, and can authorise or restrict the most concerning ones, carcinogens included. It can also phase them out. Run by ECHA, it is the engine behind much of the EU's control over cancer-causing substances.

Sources

Words to know

Tap any term to see what it means.

Browse the full glossary →

Seven adults stand close together with arms around one another and heads bowed in front of a table of white flowers, lit candles and a framed portrait.

Common questions

What is REACH?

REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) is the EU's main law governing chemicals. It requires companies to register the chemicals they make or import, along with data on hazards and safe use.

What does 'no data, no market' mean?

Under REACH, a company generally cannot sell a chemical in the EU unless it has been registered with the required safety data. The burden is on industry to show chemicals can be used safely.

How does REACH control carcinogens?

Carcinogens can be identified as Substances of Very High Concern, placed on a candidate list, and then subjected to authorisation (needing special permission to use) or restriction (limits or outright bans).

Who runs REACH?

The European Chemicals Agency (ECHA) administers REACH, working with the European Commission and member states.

Questions to ask your doctor

Being prepared helps you get the most out of your appointments. Save or print these questions.

Open my question list

Tap a question to save it to your list (kept on this device).

Human Connection Layer

Speak With Trained Specialists & Human Navigators

Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.

Free & Confidential

Talk to a trained cancer information specialist

Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.

Contact your oncology team

Locate after-hours contact numbers, portal messages, or urgent triage phone lines.

Find a patient navigator

Get one-on-one help with appointments, logistics, translation, and care coordination.

Find a genetic counselor

Discuss inherited mutation risk, family history, and genetic testing options.

Find an oncology social worker

Access emotional counseling, family support groups, and mental health resources.

Find a financial navigator

Locate copay assistance foundations, grant programs, and lodging/travel support.

Find a clinical-trial specialist

Search matching studies and speak with NCI trial information specialists.

Get urgent help

Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.

Help Us Improve This Guide

Did this explanation answer your question and help you determine your next step?

Know someone who needs this?

Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.

Email itText itWhatsApp

Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.

Knowledge Check

0 of 4 answered

  1. Q1.What does REACH stand for?
  2. Q2.What does the principle 'no data, no market' mean?
  3. Q3.How can REACH control a carcinogen?
  4. Q4.Who administers REACH?

This self-assessment checks understanding of educational content only. It is not medical advice.

Prepared by Cancer Explained's AI-assisted editorial system

Written from European Chemicals Agency material and checked line by line against the source cited below.

Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.

Last updated: 2026-08-11Next planned review: 2028-07-05

How this page was created

Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.

Editorial status — Source checked. This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.

General education — varies by person. Answers genuinely differ between people. This page explains what commonly varies and points you to your care team for your situation.

Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.

Our editorial processHow we use AIReport an error

How this page was created

Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.

Editorial status: Source checked This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.

Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.

Read more about our editorial process, our use of AI, and our corrections policy.

Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.

After using this page, do you understand what to do next?

Anonymous — we only record the answer, never who gave it.